Kilitch Drugs (India) Ltd

KILITCH
NSE· Healthcare
₹188.45
-8.54 (-4.34%)
Updated 12:14 pm IST
52W Low · ₹122.9152W High · ₹219.50
Mid Range
Market Cap
₹607.28L Cr
Volume
42.0K
Prev Close
₹180.44
ISIN
INE729D01010

Orion Score

Fundamentals-based quality & risk · not a recommendation

63/100
Watch

Kilitch Drugs (India) Ltd scores 63/100 (Watch) on the Orion Score — moderate business quality (55), strong growth (87), moderate balance-sheet safety (58) and cheap valuation (67). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality
55
Growth
87
Safety
58
Value
67

Full Orion analysis

Risk checks

  • Profit converts to cash (CFO 0.6× PAT)
  • Low debt, comfortable interest cover
  • No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 3/9Altman Z Safe(6.40)Beneish M Elevated(-2.11)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

59/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION
Low Debt
D/E 0.32x — lean balance sheet
QUALITY
Low Quality
ROCE 9.8% — poor capital efficiency
MOMENTUM
No Data
RSI unavailable

Price Chart

SMA 20
SMA 50
SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio
19.49
ROCE
9.81%
ROE (1Y)
12.36%
D/E Ratio
0.32x
OPM
23.62%
TTM EPS
₹8.91
Dividend Yield
0.00%
Qtrly Sales
₹89.60 Cr
Qtrly Profit
₹14.52 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit
QuarterRevenueNet ProfitOPMEPS
Q4 2026₹89.6₹14.5223.6%₹4.24
Q3 2026₹53.81₹4.439.7%₹1.25
Q2 2026₹48.92₹8.198.5%₹2.48
Q1 2026₹43.14₹3.035.6%₹0.92
Q4 2025₹61.23₹10.422.5%₹6.47

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit
YearRevenueNet ProfitEBITDAOPM
FY 2026₹235.47₹30.17₹47.8414.0%
FY 2025₹198.32₹26.7₹42.6314.3%
FY 2024₹153.61₹14.6₹28.6313.7%
FY 2023₹138.86₹10.45₹20.4810.3%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

CompanyMkt CapP/EROCEROED/EOPM
KILITCH ★₹607 Cr19.499.81%12.36%0.32x23.62%
SUNPHARMA₹4,27,609 Cr37.3215.73%14.72%0.06x18.90%
MAXHEALTH₹95,110 Cr66.2111.94%14.33%0.32x22.56%
AUROPHARMA₹90,029 Cr25.9412.55%9.93%0.21x15.11%
ABBOTINDIA₹57,724 Cr36.6336.14%34.46%0.04x27.01%
AJANTPHARM₹41,836 Cr39.5527.99%25.39%0.06x51.40%

Balance Sheet

All values in ₹ Crores

MetricFY 2025FY 2024FY 2023FY 2022
Total Assets₹312.78₹240.06₹219.52₹209.85
Equity₹202.33₹176.29₹151.6₹139.09
Total Debt₹49.42₹31.65₹22.19₹20.43
Cash₹9.75₹18.91₹19.79₹10.01
Net Debt₹39.68₹12.74₹2.4₹10.42
Working Capital₹89.61₹81.78₹57.53₹44.83

Shareholding Pattern

Q1 FY2027

Promoter
71.22%
FII
0%
DII
0%
Public
28.78%

Quarter-over-Quarter Trend

QuarterPromoterFIIDIIPublic
Q1 FY202771.22% ↑0%0%28.78% ↓
Q4 FY202663.77%——36.23%
Q3 FY202663.77%——36.23%
Q2 FY202663.77% ↓——36.22% ↑
Q1 FY202669.23%——30.77%
Q4 FY202569.23%——30.77%
Q3 FY202569.23%——30.76%
Q2 FY202569.23%——30.77%

Corporate Actions

Ex-DateActionDetails
2026-03-24
BONUS
Bonus 1:1

Analyse KILITCH with Orion AI

Ask: "Is Kilitch Drugs (India) Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Kilitch Drugs (India) Ltd (KILITCH) Stock

Kilitch Drugs (India) Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE729D01010. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.